UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031500 |
|---|---|
| Receipt number | R000035865 |
| Scientific Title | A phase I/II study combining mogamulizumab and lenalidomide for CCR4 positive relapsed/refractory aggressive adult T-cell leukemia/lymphoma |
| Date of disclosure of the study information | 2018/02/27 |
| Last modified on | 2022/03/03 10:04:10 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/02/27 14:01:49 | ||
| 2 | Update | 2022/03/03 10:04:10 | Recruitment status Date of IRB Last follow-up date Other related information Other related information |
